Jason Gien
Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hernias, Diaphragmatic, Congenital | 33 | 2023 | 189 | 10.200 |
Why?
| Extracorporeal Membrane Oxygenation | 15 | 2023 | 244 | 3.600 |
Why?
| Acute Kidney Injury | 12 | 2023 | 709 | 2.520 |
Why?
| Hypertension, Pulmonary | 16 | 2022 | 1794 | 2.210 |
Why?
| Bronchopulmonary Dysplasia | 10 | 2023 | 325 | 2.050 |
Why?
| Persistent Fetal Circulation Syndrome | 7 | 2016 | 132 | 1.790 |
Why?
| rho-Associated Kinases | 5 | 2016 | 84 | 1.770 |
Why?
| Infant, Newborn | 45 | 2023 | 5256 | 1.630 |
Why?
| Neovascularization, Physiologic | 6 | 2013 | 181 | 1.510 |
Why?
| Pulmonary Artery | 14 | 2018 | 1063 | 1.510 |
Why?
| Endothelin-1 | 4 | 2016 | 168 | 1.440 |
Why?
| Endothelial Cells | 10 | 2018 | 732 | 1.420 |
Why?
| Nitric Oxide | 8 | 2020 | 893 | 1.290 |
Why?
| Tracheostomy | 5 | 2016 | 102 | 1.140 |
Why?
| Lung | 15 | 2023 | 3666 | 1.100 |
Why?
| Respiration, Artificial | 4 | 2016 | 545 | 0.980 |
Why?
| Enterocolitis, Necrotizing | 2 | 2023 | 28 | 0.980 |
Why?
| Ostomy | 1 | 2023 | 3 | 0.960 |
Why?
| Infant | 24 | 2023 | 8295 | 0.930 |
Why?
| PPAR gamma | 2 | 2013 | 189 | 0.860 |
Why?
| Sheep | 14 | 2018 | 764 | 0.850 |
Why?
| Infant, Newborn, Diseases | 1 | 2023 | 106 | 0.840 |
Why?
| Patient Care Team | 3 | 2016 | 522 | 0.830 |
Why?
| Length of Stay | 7 | 2019 | 1031 | 0.800 |
Why?
| Water-Electrolyte Imbalance | 4 | 2022 | 29 | 0.800 |
Why?
| Retrospective Studies | 33 | 2023 | 12990 | 0.780 |
Why?
| Ductus Arteriosus, Patent | 3 | 2023 | 50 | 0.780 |
Why?
| Reperfusion Injury | 1 | 2023 | 276 | 0.760 |
Why?
| Blood Gas Analysis | 2 | 2021 | 69 | 0.750 |
Why?
| Prenatal Diagnosis | 2 | 2020 | 168 | 0.730 |
Why?
| Vasodilator Agents | 4 | 2016 | 328 | 0.710 |
Why?
| Transportation of Patients | 1 | 2020 | 49 | 0.710 |
Why?
| Vascular Endothelial Growth Factor A | 6 | 2023 | 527 | 0.690 |
Why?
| Respiratory Insufficiency | 2 | 2020 | 290 | 0.670 |
Why?
| Bronchodilator Agents | 1 | 2020 | 253 | 0.640 |
Why?
| Shock, Septic | 1 | 2020 | 187 | 0.630 |
Why?
| Pregnancy | 19 | 2023 | 5694 | 0.630 |
Why?
| Continuity of Patient Care | 2 | 2016 | 265 | 0.590 |
Why?
| Humans | 59 | 2023 | 119032 | 0.550 |
Why?
| Trachea | 1 | 2018 | 227 | 0.550 |
Why?
| Ventilator Weaning | 1 | 2016 | 33 | 0.550 |
Why?
| Hemodynamics | 4 | 2022 | 1004 | 0.540 |
Why?
| Umbilical Arteries | 1 | 2015 | 38 | 0.530 |
Why?
| Myocytes, Smooth Muscle | 2 | 2015 | 238 | 0.530 |
Why?
| Infant, Premature | 10 | 2023 | 480 | 0.520 |
Why?
| Radial Artery | 1 | 2015 | 74 | 0.520 |
Why?
| Herniorrhaphy | 3 | 2020 | 52 | 0.510 |
Why?
| Vasoconstrictor Agents | 2 | 2018 | 122 | 0.510 |
Why?
| Sepsis | 2 | 2020 | 531 | 0.500 |
Why?
| Female | 41 | 2023 | 61588 | 0.490 |
Why?
| Infant, Extremely Premature | 1 | 2014 | 58 | 0.480 |
Why?
| Central Nervous System Diseases | 1 | 2014 | 64 | 0.470 |
Why?
| Vasopressins | 1 | 2014 | 64 | 0.470 |
Why?
| Weight Gain | 1 | 2017 | 493 | 0.460 |
Why?
| Patient Discharge | 4 | 2021 | 794 | 0.450 |
Why?
| Oxygen Consumption | 1 | 2015 | 586 | 0.440 |
Why?
| Hypotension | 1 | 2014 | 120 | 0.440 |
Why?
| Hernia, Diaphragmatic | 3 | 2021 | 68 | 0.440 |
Why?
| Echocardiography | 5 | 2023 | 556 | 0.440 |
Why?
| Gastrostomy | 3 | 2023 | 93 | 0.430 |
Why?
| Hospital Mortality | 3 | 2021 | 814 | 0.430 |
Why?
| Practice Guidelines as Topic | 1 | 2020 | 1440 | 0.420 |
Why?
| Developmental Disabilities | 1 | 2014 | 247 | 0.400 |
Why?
| Enzyme Activation | 1 | 2012 | 828 | 0.380 |
Why?
| Communication | 1 | 2016 | 761 | 0.370 |
Why?
| Animals, Newborn | 5 | 2023 | 806 | 0.370 |
Why?
| Magnetic Resonance Imaging | 4 | 2023 | 3175 | 0.360 |
Why?
| Pulmonary Alveoli | 4 | 2014 | 384 | 0.340 |
Why?
| Bacteremia | 3 | 2019 | 161 | 0.330 |
Why?
| Kidney | 6 | 2023 | 1357 | 0.330 |
Why?
| Cardiopulmonary Resuscitation | 2 | 2022 | 225 | 0.320 |
Why?
| Endothelium, Vascular | 3 | 2013 | 907 | 0.320 |
Why?
| Lung Volume Measurements | 3 | 2023 | 46 | 0.310 |
Why?
| Sulfonamides | 3 | 2016 | 445 | 0.310 |
Why?
| Survival Rate | 4 | 2022 | 1720 | 0.300 |
Why?
| Animals | 18 | 2023 | 33399 | 0.300 |
Why?
| Fetal Growth Retardation | 3 | 2018 | 468 | 0.300 |
Why?
| Fetal Diseases | 1 | 2007 | 148 | 0.280 |
Why?
| Male | 25 | 2022 | 57818 | 0.280 |
Why?
| Ventricular Dysfunction, Left | 2 | 2022 | 374 | 0.280 |
Why?
| Morbidity | 2 | 2023 | 296 | 0.270 |
Why?
| Risk Factors | 9 | 2021 | 9003 | 0.270 |
Why?
| Receptors, Endothelin | 2 | 2016 | 49 | 0.260 |
Why?
| Urinary Tract Infections | 4 | 2019 | 136 | 0.260 |
Why?
| Fetus | 6 | 2023 | 690 | 0.250 |
Why?
| Cells, Cultured | 8 | 2014 | 4081 | 0.250 |
Why?
| Signal Transduction | 6 | 2018 | 4713 | 0.250 |
Why?
| Renal Replacement Therapy | 2 | 2022 | 70 | 0.240 |
Why?
| Treatment Outcome | 7 | 2022 | 9346 | 0.240 |
Why?
| Hernia, Umbilical | 1 | 2023 | 18 | 0.230 |
Why?
| Endotoxins | 2 | 2015 | 234 | 0.230 |
Why?
| Pulmonary Veins | 2 | 2014 | 84 | 0.230 |
Why?
| Severity of Illness Index | 5 | 2020 | 2674 | 0.230 |
Why?
| Nitric Oxide Synthase Type III | 4 | 2013 | 198 | 0.230 |
Why?
| Fundoplication | 2 | 2020 | 56 | 0.220 |
Why?
| Parturition | 1 | 2023 | 53 | 0.220 |
Why?
| Umbilical Cord | 1 | 2023 | 84 | 0.220 |
Why?
| Gestational Age | 7 | 2021 | 765 | 0.220 |
Why?
| Pulmonary Circulation | 4 | 2014 | 424 | 0.220 |
Why?
| Tracheobronchomalacia | 1 | 2022 | 14 | 0.210 |
Why?
| Tracheomalacia | 1 | 2022 | 19 | 0.210 |
Why?
| Tracheoesophageal Fistula | 1 | 2022 | 33 | 0.210 |
Why?
| Neuromuscular Blockade | 1 | 2021 | 23 | 0.200 |
Why?
| Anti-Bacterial Agents | 3 | 2019 | 1517 | 0.190 |
Why?
| Guanylate Cyclase | 2 | 2011 | 36 | 0.190 |
Why?
| Benzoates | 2 | 2011 | 40 | 0.190 |
Why?
| Interactive Ventilatory Support | 1 | 2020 | 2 | 0.190 |
Why?
| Analgesia | 1 | 2021 | 81 | 0.190 |
Why?
| Serotonin | 2 | 2013 | 309 | 0.180 |
Why?
| Infant Mortality | 2 | 2019 | 94 | 0.180 |
Why?
| Therapy, Computer-Assisted | 1 | 2020 | 60 | 0.180 |
Why?
| Adrenal Cortex Hormones | 2 | 2015 | 521 | 0.170 |
Why?
| Heart Atria | 1 | 2020 | 112 | 0.170 |
Why?
| Heart Failure | 2 | 2022 | 1968 | 0.170 |
Why?
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 2016 | 29 | 0.170 |
Why?
| Thrombelastography | 1 | 2020 | 192 | 0.170 |
Why?
| Diuretics | 2 | 2018 | 76 | 0.170 |
Why?
| Rats | 4 | 2023 | 5394 | 0.170 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2011 | 195 | 0.170 |
Why?
| Disease Models, Animal | 5 | 2015 | 3730 | 0.170 |
Why?
| Asphyxia Neonatorum | 1 | 2018 | 15 | 0.160 |
Why?
| Child | 8 | 2022 | 19137 | 0.160 |
Why?
| NF-kappa B p50 Subunit | 1 | 2018 | 26 | 0.160 |
Why?
| Intensive Care Units, Neonatal | 5 | 2018 | 178 | 0.160 |
Why?
| Surgical Flaps | 1 | 2019 | 118 | 0.160 |
Why?
| Cell Proliferation | 3 | 2015 | 2275 | 0.160 |
Why?
| Prospective Studies | 4 | 2022 | 6477 | 0.160 |
Why?
| Transcription Factor RelA | 1 | 2018 | 82 | 0.160 |
Why?
| Blood Coagulation Disorders | 1 | 2020 | 208 | 0.160 |
Why?
| Administration, Inhalation | 2 | 2016 | 656 | 0.150 |
Why?
| Monitoring, Physiologic | 1 | 2019 | 272 | 0.150 |
Why?
| Survival Analysis | 2 | 2020 | 1267 | 0.150 |
Why?
| Blood Vessels | 2 | 2016 | 187 | 0.150 |
Why?
| Brain Diseases | 1 | 2018 | 141 | 0.150 |
Why?
| Injections, Intraperitoneal | 1 | 2016 | 108 | 0.140 |
Why?
| Infant Care | 1 | 2016 | 43 | 0.140 |
Why?
| Expectorants | 1 | 2016 | 24 | 0.140 |
Why?
| Interrupted Time Series Analysis | 1 | 2016 | 45 | 0.140 |
Why?
| Rats, Sprague-Dawley | 3 | 2016 | 2478 | 0.140 |
Why?
| Ventilators, Mechanical | 1 | 2016 | 47 | 0.140 |
Why?
| Bacterial Infections | 1 | 2018 | 227 | 0.140 |
Why?
| Dimensional Measurement Accuracy | 1 | 2015 | 12 | 0.140 |
Why?
| Hypertrophy, Right Ventricular | 1 | 2016 | 146 | 0.140 |
Why?
| Cross Infection | 1 | 2018 | 205 | 0.140 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2015 | 17 | 0.140 |
Why?
| Fluorescent Antibody Technique | 1 | 2016 | 410 | 0.130 |
Why?
| Intubation, Intratracheal | 1 | 2018 | 226 | 0.130 |
Why?
| Databases, Factual | 5 | 2018 | 1231 | 0.130 |
Why?
| Steroids | 1 | 2016 | 153 | 0.130 |
Why?
| Predictive Value of Tests | 1 | 2020 | 1868 | 0.130 |
Why?
| Receptors, Calcitriol | 1 | 2015 | 56 | 0.130 |
Why?
| Preoperative Care | 1 | 2017 | 332 | 0.130 |
Why?
| High-Frequency Ventilation | 1 | 2015 | 42 | 0.130 |
Why?
| Piperidines | 1 | 2016 | 171 | 0.130 |
Why?
| Bleomycin | 1 | 2016 | 228 | 0.130 |
Why?
| Clinical Decision-Making | 1 | 2017 | 277 | 0.130 |
Why?
| Catalase | 1 | 2015 | 123 | 0.130 |
Why?
| Peptides, Cyclic | 1 | 2016 | 260 | 0.130 |
Why?
| Positive-Pressure Respiration | 1 | 2015 | 70 | 0.130 |
Why?
| Oligopeptides | 1 | 2016 | 252 | 0.130 |
Why?
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 55 | 0.120 |
Why?
| Statistics as Topic | 1 | 2015 | 307 | 0.120 |
Why?
| Arteriovenous Fistula | 1 | 2014 | 29 | 0.120 |
Why?
| Coculture Techniques | 1 | 2015 | 208 | 0.120 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 82 | 0.120 |
Why?
| Adrenergic beta-Agonists | 1 | 2015 | 132 | 0.120 |
Why?
| Cyclic GMP | 2 | 2011 | 109 | 0.120 |
Why?
| Capillaries | 1 | 2014 | 103 | 0.120 |
Why?
| Endothelin Receptor Antagonists | 1 | 2013 | 59 | 0.120 |
Why?
| Logistic Models | 4 | 2020 | 1901 | 0.120 |
Why?
| Receptor, Serotonin, 5-HT2A | 1 | 2013 | 19 | 0.110 |
Why?
| Hospitalization | 2 | 2021 | 1785 | 0.110 |
Why?
| Ligation | 1 | 2012 | 82 | 0.110 |
Why?
| Superoxide Dismutase | 1 | 2015 | 339 | 0.110 |
Why?
| Ductus Arteriosus | 1 | 2012 | 67 | 0.110 |
Why?
| Vitamins | 1 | 2014 | 159 | 0.110 |
Why?
| RNA, Small Interfering | 1 | 2015 | 564 | 0.110 |
Why?
| Amides | 1 | 2012 | 86 | 0.110 |
Why?
| Immunohistochemistry | 1 | 2016 | 1691 | 0.110 |
Why?
| Reactive Oxygen Species | 1 | 2015 | 576 | 0.110 |
Why?
| Pyridines | 2 | 2012 | 440 | 0.100 |
Why?
| Biomarkers | 2 | 2020 | 3590 | 0.100 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 333 | 0.100 |
Why?
| DNA Primers | 1 | 2012 | 533 | 0.100 |
Why?
| Protein Binding | 1 | 2016 | 1975 | 0.100 |
Why?
| RNA Interference | 1 | 2012 | 460 | 0.100 |
Why?
| In Vitro Techniques | 1 | 2012 | 1096 | 0.090 |
Why?
| Isoenzymes | 1 | 2011 | 297 | 0.090 |
Why?
| Ultrasonography, Prenatal | 2 | 2022 | 227 | 0.090 |
Why?
| Vitamin D | 1 | 2014 | 354 | 0.090 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 827 | 0.090 |
Why?
| Case-Control Studies | 1 | 2018 | 3173 | 0.090 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 815 | 0.090 |
Why?
| Prognosis | 3 | 2023 | 3443 | 0.090 |
Why?
| Transforming Growth Factor beta1 | 1 | 2011 | 164 | 0.090 |
Why?
| Hypoxia | 1 | 2016 | 963 | 0.090 |
Why?
| Blotting, Western | 1 | 2012 | 1195 | 0.090 |
Why?
| Vasodilation | 2 | 2011 | 457 | 0.090 |
Why?
| Analysis of Variance | 1 | 2012 | 1295 | 0.090 |
Why?
| Myosin-Light-Chain Phosphatase | 1 | 2008 | 4 | 0.080 |
Why?
| Dipeptides | 1 | 2008 | 51 | 0.080 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2023 | 304 | 0.080 |
Why?
| Quality Improvement | 1 | 2016 | 963 | 0.080 |
Why?
| Nitroarginine | 1 | 2007 | 48 | 0.080 |
Why?
| Postoperative Complications | 2 | 2017 | 2235 | 0.080 |
Why?
| Incidence | 3 | 2019 | 2424 | 0.080 |
Why?
| Phosphorylation | 2 | 2011 | 1634 | 0.080 |
Why?
| Enzyme Inhibitors | 2 | 2009 | 829 | 0.070 |
Why?
| Blood Pressure | 1 | 2014 | 1664 | 0.070 |
Why?
| Oxadiazoles | 3 | 2011 | 32 | 0.070 |
Why?
| Nitric Oxide Synthase | 1 | 2007 | 225 | 0.070 |
Why?
| Vascular Resistance | 3 | 2013 | 356 | 0.070 |
Why?
| Child, Preschool | 2 | 2020 | 9493 | 0.070 |
Why?
| Pulmonary Edema | 1 | 2006 | 125 | 0.070 |
Why?
| Cell Division | 1 | 2007 | 776 | 0.070 |
Why?
| Hospitals, Pediatric | 2 | 2020 | 505 | 0.070 |
Why?
| Hyperoxia | 1 | 2006 | 97 | 0.070 |
Why?
| Fetal Development | 1 | 2007 | 250 | 0.060 |
Why?
| Phenotype | 2 | 2016 | 3004 | 0.060 |
Why?
| Odds Ratio | 2 | 2018 | 996 | 0.060 |
Why?
| Cell Membrane | 1 | 2008 | 710 | 0.060 |
Why?
| Liver | 2 | 2022 | 1816 | 0.060 |
Why?
| Indomethacin | 1 | 2023 | 75 | 0.060 |
Why?
| Pregnancy Trimester, Third | 1 | 2022 | 69 | 0.050 |
Why?
| Ketanserin | 2 | 2013 | 12 | 0.050 |
Why?
| Serotonin 5-HT2 Receptor Antagonists | 2 | 2013 | 10 | 0.050 |
Why?
| Sertraline | 2 | 2013 | 26 | 0.050 |
Why?
| Water-Electrolyte Balance | 1 | 2022 | 29 | 0.050 |
Why?
| Chronic Disease | 1 | 2008 | 1637 | 0.050 |
Why?
| Creatinine | 1 | 2023 | 491 | 0.050 |
Why?
| Adult | 3 | 2022 | 31525 | 0.050 |
Why?
| Diaphragm | 1 | 2020 | 36 | 0.050 |
Why?
| Soluble Guanylyl Cyclase | 2 | 2011 | 15 | 0.050 |
Why?
| Young Adult | 1 | 2016 | 10799 | 0.050 |
Why?
| Benzodiazepines | 1 | 2021 | 123 | 0.050 |
Why?
| Hypnotics and Sedatives | 1 | 2021 | 136 | 0.050 |
Why?
| Quinoxalines | 2 | 2011 | 62 | 0.050 |
Why?
| Proteus | 1 | 2019 | 6 | 0.040 |
Why?
| Enterobacter | 1 | 2019 | 7 | 0.040 |
Why?
| Risk Assessment | 2 | 2020 | 3057 | 0.040 |
Why?
| Tertiary Care Centers | 1 | 2020 | 119 | 0.040 |
Why?
| Intubation | 1 | 2018 | 5 | 0.040 |
Why?
| Aftercare | 1 | 2021 | 194 | 0.040 |
Why?
| Oligohydramnios | 1 | 2018 | 8 | 0.040 |
Why?
| Polyhydramnios | 1 | 2018 | 18 | 0.040 |
Why?
| Apgar Score | 1 | 2018 | 16 | 0.040 |
Why?
| Cardiac Catheterization | 1 | 2022 | 541 | 0.040 |
Why?
| Protective Factors | 1 | 2019 | 92 | 0.040 |
Why?
| Intensive Care, Neonatal | 1 | 2018 | 42 | 0.040 |
Why?
| Intensive Care Units, Pediatric | 1 | 2020 | 157 | 0.040 |
Why?
| Heart | 1 | 2022 | 631 | 0.040 |
Why?
| Surgical Mesh | 1 | 2018 | 41 | 0.040 |
Why?
| Datasets as Topic | 1 | 2018 | 104 | 0.040 |
Why?
| Time Factors | 2 | 2020 | 6414 | 0.040 |
Why?
| Congenital Abnormalities | 1 | 2018 | 74 | 0.040 |
Why?
| Infant, Low Birth Weight | 1 | 2018 | 125 | 0.040 |
Why?
| Pneumonia | 2 | 2018 | 592 | 0.040 |
Why?
| Drug Utilization | 1 | 2018 | 169 | 0.040 |
Why?
| Adolescent | 1 | 2016 | 18483 | 0.040 |
Why?
| Catheterization, Central Venous | 1 | 2018 | 95 | 0.040 |
Why?
| Age of Onset | 1 | 2018 | 467 | 0.040 |
Why?
| Hydrogen-Ion Concentration | 1 | 2018 | 536 | 0.040 |
Why?
| Arterial Pressure | 1 | 2017 | 99 | 0.040 |
Why?
| Gene Expression | 2 | 2013 | 1492 | 0.040 |
Why?
| Blood Pressure Determination | 1 | 2017 | 133 | 0.040 |
Why?
| Ventricular Function, Left | 1 | 2020 | 468 | 0.040 |
Why?
| Postpartum Period | 1 | 2019 | 271 | 0.040 |
Why?
| Recurrence | 1 | 2019 | 975 | 0.040 |
Why?
| Clinical Protocols | 1 | 2017 | 238 | 0.040 |
Why?
| Antimicrobial Stewardship | 1 | 2018 | 96 | 0.030 |
Why?
| United States | 3 | 2018 | 12557 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 2 | 2011 | 1947 | 0.030 |
Why?
| Vitamin D3 24-Hydroxylase | 1 | 2015 | 15 | 0.030 |
Why?
| Staphylococcus aureus | 1 | 2019 | 394 | 0.030 |
Why?
| Birth Weight | 1 | 2018 | 465 | 0.030 |
Why?
| Calcifediol | 1 | 2015 | 29 | 0.030 |
Why?
| Risk Adjustment | 1 | 2016 | 79 | 0.030 |
Why?
| Pilot Projects | 1 | 2020 | 1420 | 0.030 |
Why?
| Escherichia coli | 1 | 2019 | 758 | 0.030 |
Why?
| Heart Ventricles | 1 | 2020 | 727 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2018 | 870 | 0.030 |
Why?
| Primary Prevention | 1 | 2016 | 185 | 0.030 |
Why?
| Amniotic Fluid | 1 | 2014 | 68 | 0.030 |
Why?
| Oxygen Inhalation Therapy | 1 | 2015 | 124 | 0.030 |
Why?
| Analgesics, Opioid | 1 | 2021 | 793 | 0.030 |
Why?
| Sheep, Domestic | 1 | 2013 | 32 | 0.030 |
Why?
| Tryptophan Hydroxylase | 1 | 2013 | 52 | 0.030 |
Why?
| Age Factors | 1 | 2020 | 2995 | 0.030 |
Why?
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 193 | 0.030 |
Why?
| Precision Medicine | 1 | 2016 | 363 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 1474 | 0.030 |
Why?
| Heart Defects, Congenital | 1 | 2018 | 703 | 0.030 |
Why?
| Hysterotomy | 1 | 2011 | 10 | 0.030 |
Why?
| Cell Aggregation | 1 | 2011 | 24 | 0.030 |
Why?
| Receptors, Serotonin | 1 | 2011 | 33 | 0.030 |
Why?
| Nitroprusside | 1 | 2011 | 88 | 0.030 |
Why?
| Cohort Studies | 1 | 2021 | 5117 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 86 | 0.020 |
Why?
| Receptor, Insulin | 1 | 2011 | 100 | 0.020 |
Why?
| Fluoxetine | 1 | 2011 | 47 | 0.020 |
Why?
| Primary Cell Culture | 1 | 2011 | 155 | 0.020 |
Why?
| Registries | 1 | 2018 | 1810 | 0.020 |
Why?
| Disease Management | 1 | 2015 | 571 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2016 | 1244 | 0.020 |
Why?
| Cell Hypoxia | 1 | 2011 | 220 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2011 | 305 | 0.020 |
Why?
| Oxygen | 1 | 2014 | 857 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 420 | 0.020 |
Why?
| Indoles | 1 | 2011 | 316 | 0.020 |
Why?
| Piperazines | 1 | 2011 | 316 | 0.020 |
Why?
| Pulmonary Wedge Pressure | 1 | 2009 | 65 | 0.020 |
Why?
| Prevalence | 1 | 2015 | 2326 | 0.020 |
Why?
| Acetylcholine | 1 | 2009 | 208 | 0.020 |
Why?
| Cell Movement | 1 | 2011 | 897 | 0.020 |
Why?
| Muscle, Smooth, Vascular | 1 | 2009 | 457 | 0.020 |
Why?
| Organ Size | 1 | 2006 | 460 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2006 | 1308 | 0.010 |
Why?
| Body Weight | 1 | 2006 | 934 | 0.010 |
Why?
| Insulin | 1 | 2011 | 2170 | 0.010 |
Why?
|
|
Gien's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|